DHTKD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.24369999976848E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.33500000000176E-05 |
Normal-vs-Stage2 |
8.040000E-03 |
Normal-vs-Stage3 |
1.70185999999184E-05 |
Normal-vs-Stage4 |
1.16289999962937E-07 |
Stage1-vs-Stage2 |
8.943600E-01 |
Stage1-vs-Stage3 |
9.529500E-02 |
Stage1-vs-Stage4 |
6.379600E-04 |
Stage2-vs-Stage3 |
2.714200E-01 |
Stage2-vs-Stage4 |
1.984220E-02 |
Stage3-vs-Stage4 |
9.423700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.17200000038231E-07 |
Normal-vs-AfricanAmerican |
3.603100E-04 |
Normal-vs-Asian |
1.17929999998712E-06 |
Caucasian-vs-AfricanAmerican |
8.838600E-01 |
Caucasian-vs-Asian |
1.253920E-02 |
AfricanAmerican-vs-Asian |
3.068200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.25959999999858E-05 |
Normal-vs-Female |
2.38620000003742E-06 |
Male-vs-Female |
8.023900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.47969999997333E-06 |
Normal-vs-Extreme_Weight |
1.50881999999575E-05 |
Normal-vs-Obese |
9.79719999999462E-05 |
Normal-vs-Extreme_Obese |
1.310570E-01 |
Normal_Weight-vs-Extreme_Weight |
3.602800E-01 |
Normal_Weight-vs-Obese |
8.401900E-02 |
Normal_Weight-vs-Extreme_Obese |
1.669630E-01 |
Extreme_Weight-vs-Obese |
2.527000E-01 |
Extreme_Weight-vs-Extreme_Obese |
2.563000E-01 |
Obese-vs-Extreme_Obese |
3.796400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.960190E-03 |
Normal-vs-Age(41-60Yrs) |
1.996500E-04 |
Normal-vs-Age(61-80Yrs) |
1.10580000045601E-07 |
Normal-vs-Age(81-100Yrs) |
1.439950E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.368800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.809600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.715000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.271200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.117200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.482000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.70690000000917E-06 |
Normal-VS-Type2 PRCC |
5.784800E-03 |
Normal-VS-KIRP CIMP |
8.13570000257613E-09 |
Normal-VS-Unclassified PRCC |
1.967320E-04 |
Type1 PRCC-VS-Type2 PRCC |
6.185800E-02 |
Type1 PRCC-VS-KIRP CIMP |
1.94460000002561E-06 |
Type1 PRCC-VS-Unclassified PRCC |
9.032400E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.09050000030031E-07 |
Type2 PRCC-VS-Unclassified PRCC |
1.649390E-01 |
KIRP CIMP-VS-Unclassified PRCC |
7.176200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.973290E-04 |
Normal-vs-N1 |
5.318300E-03 |
Normal-vs-N2 |
1.415930E-02 |
N0-vs-N1 |
9.201000E-01 |
N0-vs-N2 |
2.500000E-01 |
N1-vs-N2 |
4.173200E-01 |
|
|